Research & Publications

Peer-Reviewed Research

Full journal manuscripts, including external studies that used Forian data.

Journal
2026

Understanding Patient Experience in the Management and Prioritization of MASH and Comorbidities: Results from a Claims Analysis and Qualitative Patient Interviews

Hadac J., Anand A., Jones J., van der Pluijm W., Wu A., Fok L.

Metabolism · April 2026

Read →
Journal
2026

Impact of Selumetinib on Long-Term Pain Medication Utilization in Pediatric Patients: A Retrospective US Claims Database Study

Lyons G., Dettling T., Bowling A., Anand A., Sicilia M., van der Pluijm W., Guikema B., Meade J.

Pain and Therapy · 2026

Read →
JournalExternal
2026

Comparative Effectiveness of Diroximel Fumarate vs. Dimethyl Fumarate in Persons with Multiple Sclerosis: A US Claims Analysis of Relapse Outcomes

Bandari D., Conway D., Dong L., et al.

Advances in Therapy · 2026

Read →
JournalExternal
2024

Estimation of the Eligible Population for Resmetirom Among Adults in the United States for Treatment of Non-Cirrhotic NASH with Moderate-to-Advanced Liver Fibrosis

Fishman J., Kim Y., Charlton M.R., Smith Z.J., O'Connell T., Bercaw E.M.

Advances in Therapy · 2024

Read →

Conference Work

Posters, podium presentations, and published or indexed conference abstracts.

AbstractNew
2026

Effect of Selumetinib Treatment on Long-Term Prescription Pain Medication Utilization in Adults: A Retrospective Study of a U.S. Claims Database

Lyons G., Jordan J., Dettling T., Bowling A., Anand A., Sicilia M., Meade J.

Neurology · June 2026 · Published abstract

Read →
Poster
2026

Machine Learning to Differentiate Congestive Heart Failure Onset Among High-Risk Patients Identified by the Framingham Risk Score

Sicilia M., van der Pluijm W.

ISPOR · May 2026

Read →
Poster
2026

Declining Baseline HbA1c at GLP-1 Receptor Agonist Initiation in U.S. Adults with Type 2 Diabetes, 2015–2024

Panthari A., Sicilia M., van der Pluijm W.

ISPOR · May 2026

Read →
Poster
2026

Real-World Concordance With the Framingham Stroke Risk Model in Atrial Fibrillation and Identification of Additional Significant Features

Sicilia M., van der Pluijm W.

ISPOR · May 2026

Read →
Poster
2026

Association Between GLP-1 Receptor Agonist Initiation and Alcohol Use Disorder and Alcohol-Related Medical Conditions in a U.S. Administrative Claims Database

van der Pluijm W., Neilson D., Anand A.

ISPOR · May 2026

Read →
Poster
2026

Observed Cardiovascular Disease Prevalence Among Obese and Type 2 Diabetes Patients With and Without GLP-1 Treatment

Panthari A., Sicilia M., van der Pluijm W.

ISPOR · May 2026

Read →
Poster
2026

Trends in Preeclampsia Prevalence and Comorbidity Burden Among Pregnant Women Using U.S. Administrative Claims Data

van der Pluijm W., Sicilia M., Anand A.

ISPOR · May 2026

Read →
Poster
2026

Observed Real-World Diagnosis and Specialist Visit Patterns in Newly Diagnosed and Relapsing MS Patients

Sicilia M.

ISPOR · May 2026

Read →
Poster
2026

Genomic and Ancestry-Associated Determinants of Survival in Gynecologic Cancers

Chambers L., Ramu A., Aushev V., Rojahn S., Antonopoulos A., Scalise C., Salmasi F., Liu M., ElNaggar A., Arend A.

AACR · Apr 2026

Read →
Poster
2026

Genetic Characterization and Clinical Manifestations in Adults with Hypophosphatasia in the United States

Lyons G., Vlasnik J., Jastrab A., Abramson A., Sullivan B., Anand A., Sicilia M., Panthari A., Peroutka C.

ACMG · Mar 2026

Read →
Poster
2026

Patient Support and Real-World Evidence Generation in Rare Disease: A Case Study in Hypophosphatasia

Lyons G., Vlasnik J., Mowrey W., Rangel-Pozzo A., Jastrab A., Abramson A., Sullivan B., Anand A., Sicilia M., Panthari A., Peroutka C.

ISPOR · May 2026

Read →
Presentation
2026

Weighted Statistical Methods for Novel Feature Selection: Improving Binary Classification in RWE Studies Through Prevalence-Aware Metrics

Anand A., Sicilia M.

PMSA · May 2026

Read →
Abstract
2026

Circulating Tumor DNA (ctDNA) Clearance Dynamics in Microsatellite Instability-High Metastatic (MSI-H) Colorectal Cancer Treated with Immune Checkpoint Inhibitors

Robinson H.R., Lieu C.H., Aushev V.N., Tin A., Nousome D., Ortiz J.B., Sharma S., Lentz R., Jurdi A.

AACR 2026 · Cancer Research

Read →
Abstract
2025

Effect of Selumetinib Treatment on Long-Term Pain Medication Utilization in Pediatric Patients: A Retrospective Study of a US Claims Database

Meade J., Lyons G., Anand A., Sicilia M., van der Pluijm W., Bowling A., Guikema B., Dettling T.

Neuro-Oncology · 2025 · Abstract QOL-27

Read →
Poster
2025

Understanding Patient Experience in the Management and Prioritization of MASH and Comorbidities: Results from a Claims Analysis and Qualitative Patient Interviews

Hadac J., Anand A., Jones J., Neilson D., van der Pluijm W., Wu A., Fok L.

WCIRDC · Dec 2025

Read →
Poster
2025

Effect of Selumetinib Treatment on Long-Term Pain Medication Utilization in Pediatric Patients: A Retrospective Study of a US Claims Database

Meade J., Lyons G., Anand A., Sicilia M., van der Pluijm W., Bowling A., Guikema B., Dettling T.

SNO · Nov 2025

Read →
Poster
2025

Corticosteroid Toxicity and Related Healthcare Resource Utilization in Patients with Myasthenia Gravis in the USA

Ragole T., Blackowicz M., Weiskopf E., Anand A., Sicilia M.

AANEM · Oct 2025

Read →
Poster
2025

Estimating Genital Herpes Prevalence and Treatment Patterns Among US Healthcare-Engaged Individuals: Insights From Claims Data

Lian L., Johnston C., Seo M., Kitrinos K., Gaggar A., Deer J.

STI & HIV World Congress · Jul 2025

Read →
Poster
2025

Estimating Genital Herpes Prevalence and Treatment Patterns Among US Healthcare-Engaged Individuals: Insights from Claims Data

Lian L., Johnston C., Seo M., Kitrinos K., Gaggar A., Deer J.

ESCMID · Apr 2025

Read →
Poster
2025

Concomitant Usage of Contraindicated Medications in Patients with Atrial Fibrillation: A Comparison of RWD Sources in the US

Sicilia M., van der Pluijm W.

ISPOR · May 2025

Read →
Poster
2025

Trends in GLP-1 Utilization for Diabetes and Obesity in the US: A Retrospective Analysis (2017–2023)

van der Pluijm W., Sicilia M.

ISPOR · May 2025

Read →
Poster
2025

Baseline BMI and HbA1c Trends in US Diabetic Patients Initiating GLP-1 Therapy: A Retrospective Cohort Study

van der Pluijm W., Sicilia M.

ISPOR · May 2025

Read →
Poster
2025

Early Breast Cancer in the US and Germany: A Comparison of Real-World Screening and Treatment

Simeone J., Menou S., van der Pluijm W., Sicilia M.

ISPOR · May 2025

Read →
Poster
2025

Longitudinal Associations of Corticosteroid Dose with Corticosteroid Toxicity in Patients with Myasthenia Gravis in the USA

Ragole T., Blackowicz M., Weiskopf E., Anand A., Sicilia M., Wolfe G.

MDA · Mar 2025

Read →
Presentation
2024

Using Longitudinal Claims Data to More Accurately Predict Response Uptake Curves in Rare & Ultra Rare Disease

Rosenblatt J., Rosenberg R., Anand A.

PMSA · May 2024

Read →
Poster
2024

Emergency Room Utilization Among Multiple Sclerosis Patients Treated with Disease-Modifying Therapy in a Real-World Hybrid Claims Database

Kuranz S.

ISPOR · May 2024

Read →
Poster
2024

Patterns of Treatment Initiation by Sarcoidosis Type in a Real-World Hybrid Claims Database

Kuranz S., Westall T.

ISPOR · May 2024

Read →
Poster
2024

Learnings from Linking Electronic Medical Record Patient Cohorts with Consumer SDOH Data

Duchen J., Schulman K.L.

AMCP · JMCP · Platinum Poster Award

Read →
Abstract
2023

Progression to ESRD Among White, Black and Hispanic Diabetic Kidney Disease Patients Treated From Multiple Linked Claims Databases

Kuranz S.

ICPE · Aug 2023

Read →
Abstract
2023

Association of Cannabis Use with Real-World Time to Treatment Discontinuation in Advanced Cancer Patients Initiating Immune Checkpoint Inhibition

Zylla D., Knowlton G., Gilmore G., Pawloski P.A., Salz T., Kulkarni A.A., Cowger J., Kuranz S.

ASCO · Jun 2023

Read →
Abstract
2023

Real World Evidence on the Use of ECMO in Hospitalized COVID-19 Patients: Results From a Linked Closed and Open Claims Database in the US

Kuranz S., Neilson D.

ISPOR · May 2023

Read →
Abstract
2023

Adherence and Persistence with SGLT-2 Inhibitors Among White and Black Diabetic Kidney Disease Patients: Real-World Evidence From a Large US Claims Database

Kuranz S.

ISPOR · May 2023

Read →
Abstract
2023

Estimating the Cost of End-of-Life Care Among US Adults: Real-World Evidence Using a Case-Crossover Study Design

Kuranz S., Neilson D., van der Pluijm W.

ISPOR · May 2023

Read →
Abstract
2023

Real-World Evidence on the Association Between the Use of Cannabis and Healthcare Resource Utilization Among Patients With Chronic Post-Traumatic Stress Disorder

Kuranz S., Anand A., van der Pluijm W.

ISPOR · May 2023

Read →
Abstract
2022

Epidemiological Estimate of the Prevalence of the Coded Nonalcoholic Steatohepatitis (NASH) Population in the US Using an Administrative Claims Dataset

Fishman J., Hubbert A., van der Pluijm W., Zhang C., Sun An Y.

ISPOR Europe · Nov 2022

Read →
Poster
2022

The Cost of Care Among Infantile and Child Spinal Muscular Atrophy Patients: RWE From a Large Claims Database

Kuranz S., van der Pluijm W.

ISPOR Europe · Nov 2022

Read →

Forian Perspectives

White papers, industry articles, interviews, and podcasts.

Industry Article
2026

Understanding Heart Failure Progression: New Insights From Machine Learning Applied to High-Risk Patients

Sicilia M., van der Pluijm W.

The Evidence Base

Read →
Industry Article
2026

From Claims to Commercial Strategy: Finding Actionable Insights in Rare Disease Data

Paine L.

The Evidence Base

Read →
Podcast
2026

In Conversation With Forian's Ben Miller: Applied AI, Predictive Models, and the Future of Agentic Systems

Miller B.

FeatureByte

Read →
Industry Article
2025

Unlocking Longitudinality: How Hybrid Claims Data Transforms RWE/HEOR Studies

van der Pluijm W., Sicilia M.

The Evidence Base

Read →
Industry Article
2025

Choosing the Right Data for the Right Insight: Comparing US Real-World Data Sources in the Context of Atrial Fibrillation

Sicilia M.

The Evidence Base

Read →
Industry Article
2024

Beyond Access: How Wealth and Race Shape GLP-1 Treatment Outcomes in Diabetes and Weight Loss

Sicilia M.

The Evidence Base

Read →
White Paper
2023

Introduction to CHRONOS: Forian's Hybrid Real-World Data Ecosystem

Kuranz S.

Forian

Read →
Interview
2023

Real-World Evidence Generation From Hybrid Claims Data: An Interview With Seth Kuranz, Forian Inc.

Kuranz S.

The Evidence Base

Read →
Podcast
2023

Understanding and Leveraging Healthcare Data with Paul Reuscher

Rhyee C. (Host)

TD Cowen Insights: FutureHealth Podcast Series · Aug 2023

Read →

Commercial & Market Intelligence

Public examples of biopharmaceutical companies using Forian data for epidemiology, market sizing, patient identification, launch planning, commercial targeting, and investor communications.